Carle Illinois College of Medicine All Events

Back to Listing

RISE Seminar by Jordan Marsh "Assessment of Iron Content in the Eyes of Patients with Age-Related Macular Degeneration using 7T MRI"

Event Type
Seminar/Symposium
Sponsor
Carle Illinois College of Medicine
Location
MSB Auditorium (Room 274) and Virtually via Zoom
Date
Oct 22, 2021   12:00 - 1:00 pm  
Speaker
Jordan Marsh
Registration
Registration Required for In-Person Attendance at MSB Auditorium
Contact
Angie Ellis
E-Mail
amellis@illinois.edu
Phone
217-300-1910
Views
44
Originating Calendar
Carle Illinois College of Medicine General Events

RISE Seminars: Research & Innovation from Student Entrepreneurs

 

Jordan Marsh

 

Assessment of Iron Content in the Eyes of Patients with Age-Related Macular Degeneration using 7T MRI

 

October 22, 2021

 

12:00 p.m - 1:00 p.m.

 

Medical Sciences Building Auditorium Room 274

Virtually at https://go.medicine.illinois.edu/RISESeminars

 

Lunch will be provided with advanced registration by 4:30 p.m. on October 19th 

Registration is required for in-person attendance at MSB Auditorium

 

Abstract: Age-related macular degeneration (ARMD) is a progressive, multifactorial disease that leads to degeneration of the portion of the retina responsible for central vision. Post-mortem examinations of ARMD retinas have shown elevated levels of both chelatable and non-chelatable iron, consistent with the hypothesis that iron dysregulation is a potential pathologic pathway in the disease. The objective of this study is to determine if statistically significant differences in iron levels exist in ARMD retinas in vivo by utilizing 7T MRI. We will use a case-control design in which patients with ARMD will be compared against age-matched healthy controls to determine levels of iron in the retina.  We hypothesize that ARMD patients will show statistically significant elevations of iron compared to healthy controls using 7T MRI, as reflected by a more rapid decay of MRI signal in affected areas. The potential impact of this study is elucidating a possible pathophysiological mechanism for ARMD: iron dysregulation. Furthermore, if findings are significant for elevated iron levels in ARMD patients, then therapeutic approaches could be designed to potentially reduce ARMD symptoms.

 

 

Jordan Marsh is an MS2 at Carle Illinois College of Medicine. He received a B.S. in Chemical Engineering with a minor in Chemistry from the University of Utah. He spent two years working as a Patent Examiner at the USPTO before matriculating at CIMED in 2020. Research interests include discovering systemic disease biomarkers in the eye, critical periods in early brain development, improving treatments for retinal disease, among many others.

link for robots only